John Zic, MD
Dermatology · Nashville, TNNPI 1942210877
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,270 of the $3,660 with a category attached, or 89.4%. Kyowa Kirin, Inc. accounts for 96.9% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $3,410, more than ten times the $14 reported in 2021. That places this record below the midpoint for dermatology clinicians in TN, where the typical reported total is $3,452.
Across 5 payments — averaging $731.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyowa Kirin, Inc.$4K
- Johnson & Johnson$100
- Bausch Health US, LLC$14
Across 8 payments — averaging $10,818 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Co., Ltd.$87K
What the payments were for
- Consulting fees$3,27089%
- Food & beverage$2758%
- Education$1143%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kyowa Kirin, Inc. | 3 | $3,545 |
| Johnson & Johnson | 1 | $100 |
| Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- POTELIGEO$3,545
How this compares
$3,660 in reported general payments places this provider in the 50th percentile of 209 dermatology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bexarotene | 170 | $573,628 |
| Humira PenAdalimumab | 12 | $146,937 |
| Dupixent PenDupilumab | 24 | $143,384 |
| Humira(Cf) PenAdalimumab | 13 | $124,191 |
| Calcipotriene | 27 | $3,460 |
| Fluorouracil | 23 | $1,767 |
| Ketoconazole | 97 | $1,650 |
| Fluocinonide | 38 | $1,625 |
| Clindamycin Phosphate | 11 | $1,532 |
| Tacrolimus | 17 | $1,360 |
| Clobetasol Propionate | 40 | $1,166 |
| MethotrexateMethotrexate Sodium | 50 | $939 |
| Triamcinolone Acetonide | 93 | $858 |
| Metronidazole | 17 | $826 |
| Mupirocin | 61 | $648 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Nashville
- Kimberly VincentNashville$1.5M
- Adrian RodriguezNashville$1.1M
- Michael GoldNashville$748K
- David HorowitzNashville$34K
- Thomas DayNashville$16K
- Jeffrey ZwernerNashville$15K
- Shi ChengNashville$10K
- Allyson Brooke EasthamNashville$9K
- Ashley MatthewsNashville$9K
- Heidi RindererNashville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.